Human clearance prediction: shifting the paradigm (Q37554400)

21 August 2017

1 reference

title

Human clearance prediction: shifting the paradigm (English)

1 reference

21 August 2017

Thierry Lavé

1 reference

21 August 2017

Kathryn Chapman

series ordinal

1 reference

21 August 2017

Paul Goldsmith

series ordinal

1 reference

21 August 2017

Malcolm Rowland

series ordinal

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

Expert Opinion on Drug Metabolism & Toxicology

21 August 2017

published in

1 reference

21 August 2017

1 reference

21 August 2017

1 reference

21 August 2017

page(s)

1039-1048

1 reference

Physiologically based pharmacokinetics in drug development and regulatory science: a workshop report (Georgetown University, Washington, DC, May 29-30, 2002).

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

On the anticipation of the human dose in first-in-man trials from preclinical and prior clinical information in early drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Can the pharmaceutical industry reduce attrition rates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Application of a generic physiologically based pharmacokinetic model to the estimation of xenobiotic levels in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Integrating in vitro ADMET data through generic physiologically based pharmacokinetic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

The chimpanzee (Pan troglodytes) as a pharmacokinetic model for selection of drug candidates: model characterization and application

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Simulation and prediction of in vivo drug metabolism in human populations from in vitro data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Prediction of in vivo drug clearance from in vitro data. I: impact of inter-individual variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Prediction of in vivo hepatic clearance from in vitro data using cryopreserved human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Predicting human drug glucuronidation parameters: application of in vitro and in silico modeling approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

The "albumin effect" and in vitro-in vivo extrapolation: sequestration of long-chain unsaturated fatty acids enhances phenytoin hydroxylation by human liver microsomal and recombinant cytochrome P450 2C9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Crystal structure of rat intestinal fatty-acid-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: an application of serum incubation method

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

In vitro-in vivo correlation of hepatobiliary drug clearance in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

In vitro biliary clearance of angiotensin II receptor blockers and 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in sandwich-cultured rat hepatocytes: comparison with in vivo biliary clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Interspecies pharmacokinetic comparisons and allometric scaling of napsagatran, a low molecular weight thrombin inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Interspecies scaling of biliary excreted drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Use of canalicular membrane vesicles (CMVs) from rats, dogs, monkeys and humans to assess drug transport across the canalicular membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Absolute difference of hepatobiliary transporter multidrug resistance-associated protein (MRP2/Mrp2) in liver tissues and isolated hepatocytes from rat, dog, monkey, and human.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of 'bottom-up' vs 'top-down' recogn

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Inter-species extrapolation of pharmacokinetic data of three prostacyclin-mimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Prediction of human pharmacokinetics - renal metabolic and excretion clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Interindividual variability in inhibition and induction of cytochrome P450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Prediction of human pharmacokinetics--gut-wall metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

The human intestinal cytochrome P450 "pie".

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine*

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

In vitro methods to study intestinal drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Prediction of intestinal first-pass drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Functional interactions between P-glycoprotein and CYP3A in drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Prediction of metabolic drug clearance in humans: in vitro-in vivo extrapolation vs allometric scaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Prediction of hepatic metabolic clearance: comparison and assessment of prediction models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Applications of physiologically based absorption models in drug discovery and development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Mechanistic approaches to volume of distribution predictions: understanding the processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

Prediction of Hepatic Clearance from Microsomes, Hepatocytes, and Liver Slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903099649

10.1517/17425250903099649

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference